How to make these words into chief complain, vomiting for 10 times one day prior admision
S- patient vomiting for 5 times per day for 10 days before admission, O- 10 days prior admission, c- vomit was clear in colour, has all the food contain that she consumes. Technically whatever she eats, she vomitted everything out, R- none, A- headache, stomach ache, T- 10 days, E- whatever she eats, R-none.., S-7/10. This patei
| S — Site/Symptom | Vomiting |
| O — Onset | 10 days prior to admission |
| C — Character | Clear in colour, containing undigested food particles; patient vomits out everything she consumes |
| R — Radiation | None |
| A — Associated symptoms | Headache, abdominal pain (stomach ache) |
| T — Time/Duration | 10 days, occurring approximately 5 times per day |
| E — Exacerbating/Relieving factors | Exacerbated by food/drink intake — vomiting is triggered by eating anything; no relieving factors noted |
| S — Severity | 7/10 |
The patient presented with a 10-day history of vomiting, occurring approximately 5 episodes per day. The vomitus was clear in colour and contained undigested food, with the patient reporting that she vomits out everything she consumes. Onset was 10 days prior to admission. There are no relieving factors. Associated symptoms include headache and abdominal pain. Vomiting is exacerbated by any oral intake. The patient rates the severity of her discomfort at 7/10.
Thie patient is a known case of DM for 4 years and BRCA in 2020
| Condition | Details |
|---|---|
| Diabetes Mellitus (DM) | Known case for 4 years |
| Breast Cancer (BRCA) | Diagnosed in 2020 |
The patient is a known case of Diabetes Mellitus (DM) for the past 4 years. She also has a history of breast cancer (BRCA), diagnosed in 2020.
The patient presented with a 10-day history of vomiting, occurring approximately 5 episodes per day. The vomitus was clear in colour and contained undigested food, with the patient reporting that she vomits out everything she consumes. There are no relieving factors. Associated symptoms include headache and abdominal pain. Vomiting is exacerbated by any oral intake. The patient rates the severity at 7/10.She is a known case of Diabetes Mellitus for 4 years and was diagnosed with breast cancer in 2020.
She gone masectomy in 2020, due to brca
| Condition | Details |
|---|---|
| Diabetes Mellitus (DM) | Known case for 4 years |
| Breast Cancer (BRCA) | Diagnosed in 2020 |
| Procedure | Year | Indication |
|---|---|---|
| Mastectomy | 2020 | Breast cancer (BRCA) |
The patient is a known case of Diabetes Mellitus (DM) for the past 4 years. She was diagnosed with breast cancer (BRCA) in 2020 and subsequently underwent a mastectomy the same year.
Chief Complaint: Vomiting ×5 episodes/day, 10 days prior to admission.HPI: The patient presented with a 10-day history of vomiting, occurring approximately 5 episodes per day. The vomitus was clear in colour and contained undigested food, with the patient reporting that she vomits out everything she consumes. There are no relieving factors. Associated symptoms include headache and abdominal pain. Vomiting is exacerbated by any oral intake. The patient rates the severity at 7/10.PMH: Known case of Diabetes Mellitus for 4 years. Diagnosed with breast cancer in 2020.PSH: Underwent mastectomy in 2020 for breast cancer.
She is undergoing chemotherapy for 6 months once and taking the drugs related to her cancer
| Treatment | Details |
|---|---|
| Chemotherapy | Ongoing, once every 6 months |
| Cancer-related medications | Currently on (specific drugs not stated) |
The patient is currently undergoing chemotherapy, administered once every 6 months. She is also on cancer-related medications (specific drugs not documented at this time).
⚠️ Clinical Note: The patient's vomiting is highly likely to be chemotherapy-induced nausea and vomiting (CINV), which is a well-known side effect of chemotherapy. This should be considered in the differential diagnosis.
Chief Complaint: Vomiting ×5 episodes/day, 10 days prior to admission.HPI: The patient presented with a 10-day history of vomiting, occurring approximately 5 episodes per day. The vomitus was clear in colour and contained undigested food particles, with the patient reporting that she vomits out everything she consumes. There are no relieving factors. Associated symptoms include headache and abdominal pain. Vomiting is exacerbated by any oral intake. The patient rates the severity at 7/10.PMH: Known case of Diabetes Mellitus for 4 years. Diagnosed with breast cancer (BRCA) in 2020.PSH: Underwent mastectomy in 2020 for breast cancer.Current Treatment: Currently undergoing chemotherapy (once every 6 months) and is on cancer-related medications.
Possible positive systemic review in this case
| Symptom | Relevance |
|---|---|
| Nausea | CINV, DM gastroparesis |
| Vomiting ✓ | Already confirmed — 5×/day |
| Abdominal pain ✓ | Already confirmed |
| Loss of appetite (anorexia) | Chemo side effect |
| Weight loss | Cancer/chemo-related |
| Constipation | Opioid or chemo-induced |
| Bloating/early satiety | DM gastroparesis |
| Symptom | Relevance |
|---|---|
| Headache ✓ | Already confirmed |
| Peripheral neuropathy | DM complication, chemo toxicity |
| Dizziness/lightheadedness | Dehydration from vomiting |
| Brain metastases symptoms | BRCA can metastasise to brain — headache + vomiting raises concern |
| Symptom | Relevance |
|---|---|
| Fatigue/lethargy | Chemo, anaemia, DM |
| Fever/chills | Chemotherapy-induced neutropenia |
| Night sweats | Cancer-related |
| Weight loss | Malignancy, poor oral intake |
| Symptom | Relevance |
|---|---|
| Polyuria / polydipsia | Poorly controlled DM |
| Hypoglycaemic episodes | Reduced oral intake + DM medications |
| Blurred vision | DM complication |
| Symptom | Relevance |
|---|---|
| Palpitations | Electrolyte imbalance from vomiting (hypokalaemia) |
| Chest pain | Some chemo agents are cardiotoxic (e.g. doxorubicin) |
| Leg swelling | DVT risk in cancer patients |
| Symptom | Relevance |
|---|---|
| Shortness of breath | Anaemia (chemo), pleural effusion, lung mets |
| Cough | Lung metastases from BRCA |
| Symptom | Relevance |
|---|---|
| Bone pain | Bone metastases (BRCA commonly metastasises to bone) |
| Joint pain/myalgia | Chemo side effect |
- Headache + vomiting → Rule out brain metastases (BRCA can spread to CNS)
- Bone pain → Rule out bone metastases
- Fever + mouth ulcers → Rule out neutropenic sepsis (chemotherapy)
- Hypoglycaemia symptoms → Patient on DM meds but not eating due to vomiting — high risk
Pmx
| Finding | Relevance |
|---|---|
| Ill-looking / lethargic appearance | Prolonged vomiting, chemo side effects |
| Cachexia / weight loss | Malignancy, poor oral intake |
| Pallor | Chemotherapy-induced anaemia |
| Dehydration signs — dry mucous membranes, sunken eyes, reduced skin turgor | 10 days of vomiting |
| Mastectomy scar on chest wall | Surgical history |
| Parameter | Expected Finding |
|---|---|
| BP | Low (hypotension) — dehydration |
| HR | Tachycardia — dehydration, pain |
| Temperature | Possible fever — neutropenic sepsis |
| RR | May be elevated |
| SpO₂ | Usually normal unless lung mets |
| BMI/Weight | Likely reduced |
| Finding | Relevance |
|---|---|
| Dry lips / dry mucous membranes | Dehydration |
| Oral ulcers (mucositis) | Chemotherapy side effect |
| Pale conjunctiva | Anaemia |
| Jaundice (scleral icterus) | Liver metastases |
| Finding | Relevance |
|---|---|
| Tachycardia | Dehydration, anaemia |
| Reduced capillary refill time | Dehydration |
| Irregular rhythm | Hypokalaemia from vomiting |
| Finding | Relevance |
|---|---|
| Reduced air entry | Pleural effusion (BRCA metastases) |
| Dullness on percussion | Pleural effusion |
| Finding | Relevance |
|---|---|
| Epigastric tenderness | Gastritis, gastroparesis |
| Generalised tenderness | Associated abdominal pain |
| Hepatomegaly | Liver metastases from BRCA |
| Reduced bowel sounds | Ileus from electrolyte imbalance |
| Succussion splash | Gastric outlet obstruction (if present) |
| Finding | Relevance |
|---|---|
| Papilloedema (on fundoscopy) | Raised ICP — brain metastases |
| Focal neurological deficit | Brain metastases |
| Peripheral neuropathy — reduced sensation in glove & stocking distribution | DM + chemo neurotoxicity |
| Positive Romberg's | Peripheral neuropathy |
| Finding | Relevance |
|---|---|
| Bony tenderness — spine, ribs, pelvis | Bone metastases |
| Lymphadenopathy — axillary, supraclavicular | Breast cancer spread |
| Finding | Relevance |
|---|---|
| Alopecia (hair loss) | Chemotherapy |
| Mastectomy scar | PSH confirmation |
| Peripheral oedema | Hypoalbuminaemia, DVT |
- Signs of dehydration — top priority given 10 days of vomiting
- Neurological signs — headache + vomiting → rule out brain mets
- Fever + pallor → neutropenic sepsis
- Hepatomegaly / lymphadenopathy → metastatic disease
Left Masectomy in 2020 due to brca, hysterectomy in 2013 due to fibroid
| Procedure | Year | Indication |
|---|---|---|
| Left Mastectomy | 2020 | Left breast cancer (BRCA) |
| Hysterectomy | 2013 | Uterine fibroids |
The patient underwent a left mastectomy in 2020 due to left breast cancer (BRCA). She also had a hysterectomy in 2013 for uterine fibroids.
Chief Complaint: Vomiting ×5 episodes/day, 10 days prior to admission.HPI: The patient presented with a 10-day history of vomiting, occurring approximately 5 episodes per day. The vomitus was clear in colour and contained undigested food particles, with the patient reporting that she vomits out everything she consumes. There are no relieving factors. Associated symptoms include headache and abdominal pain. Vomiting is exacerbated by any oral intake. The patient rates severity at 7/10.PMH: Known case of Diabetes Mellitus for 4 years. Diagnosed with left breast cancer (BRCA) in 2020.PSH:
- Left mastectomy (2020) — left breast cancer
- Hysterectomy (2013) — uterine fibroids
Current Treatment: Currently undergoing chemotherapy (once every 6 months) and is on cancer-related medications.
On inspection of the chest — left mastectomy scar expected on the left chest wall. Abdomen — hysterectomy scar (midline or Pfannenstiel) expected on the lower abdomen.
Medications are for dm, chemo and some cqncer med
| Category | Medication | Details |
|---|---|---|
| Diabetes Mellitus | Oral hypoglycaemic agents (OHA) and/or Insulin | Specific drug not stated |
| Chemotherapy | Chemotherapy agent (e.g. Taxane/Anthracycline-based) | Once every 6 months |
| Cancer medications | Hormonal therapy / targeted therapy (e.g. Tamoxifen, Trastuzumab) | Specific drug not stated |
The patient is currently on medications for Diabetes Mellitus (OHA and/or insulin), chemotherapy (administered once every 6 months), and cancer-related medications (likely hormonal or targeted therapy for breast cancer). Specific drug names were not documented at this time.
| Medication | Relevance to Current Complaint |
|---|---|
| Chemotherapy | Most likely cause of vomiting — CINV (Chemotherapy-Induced Nausea & Vomiting) |
| DM medications | Risk of hypoglycaemia — patient not tolerating oral intake for 10 days |
| Tamoxifen / Hormonal therapy | Can also cause nausea and GI upset |
| Trastuzumab | Can cause nausea, vomiting, diarrhoea |
CC: Vomiting ×5 episodes/day, 10 days PTA.HPI: 10-day history of vomiting, 5 episodes/day. Vomitus clear, containing undigested food. No relieving factors. Associated headache and abdominal pain. Exacerbated by oral intake. Severity 7/10.PMH: DM (4 years), Left breast cancer (2020).PSH: Left mastectomy (2020) — BRCA; Hysterectomy (2013) — fibroids.Medications: DM medications, chemotherapy (once every 6 months), cancer-related medications. Specific drugs not documented.
Patient will not get period afet the hysterectomy right
| Type | What was removed | Period? |
|---|---|---|
| Total hysterectomy | Uterus + cervix | ❌ No periods |
| Radical hysterectomy | Uterus + cervix + surrounding tissue | ❌ No periods |
| Total + bilateral salpingo-oophorectomy (BSO) | Uterus + cervix + both ovaries + tubes | ❌ No periods + surgical menopause |
Since her hysterectomy was for fibroids, it was most likely a total hysterectomy — so no periods after 2013. ✅
| Ovaries removed? | Periods | Menopause |
|---|---|---|
| No (ovaries kept) | No periods | Natural menopause still occurs at normal age |
| Yes (BSO) | No periods | Immediate surgical menopause — hot flushes, mood changes, osteoporosis risk |
Under Gynaecological/Obstetric History (GynObs):"Patient underwent hysterectomy in 2013 for uterine fibroids. She has had no menstrual periods since 2013. Menopausal status to be clarified based on whether oophorectomy was performed concurrently."
Since she is on breast cancer treatment (likely Tamoxifen or an aromatase inhibitor), these drugs also suppress oestrogen — further confirming she would have no menstrual activity regardless.
Give me the sample general and specific examination findings in this case
| Parameter | Finding | Interpretation |
|---|---|---|
| Temperature | 37.8°C (low-grade fever) | Possible neutropenic sepsis |
| Blood Pressure | 100/70 mmHg (low) | Dehydration from vomiting |
| Heart Rate | 102 bpm (tachycardia) | Dehydration, anaemia |
| Respiratory Rate | 20 breaths/min | Slightly elevated |
| SpO₂ | 97% on room air | Acceptable |
| BMI | Underweight | Poor oral intake, malignancy |
| Blood Glucose | Low/unstable | Not eating for 10 days + DM meds |
| Finding | Interpretation |
|---|---|
| Ill-looking, lethargic | Prolonged vomiting, chemo effects |
| Cachexic appearance | Malignancy, poor nutritional intake |
| Pallor | Chemotherapy-induced anaemia |
| Alopecia (hair loss) | Chemotherapy |
| No jaundice | No liver metastases (likely) |
| No cyanosis | Peripheral perfusion intact |
| No clubbing | — |
| No lymphadenopathy | Or positive — metastatic spread |
| Finding | Interpretation |
|---|---|
| Dry lips and mucous membranes | Dehydration |
| Sunken eyes | Dehydration |
| Reduced skin turgor | Dehydration |
| Reduced urine output | Dehydration |
| Prolonged capillary refill >2 sec | Poor peripheral perfusion |
- Abdomen flat/scaphoid
- Pfannenstiel or midline scar noted at lower abdomen — consistent with hysterectomy (2013)
- No visible distension
- No visible peristalsis
- Epigastric tenderness on light palpation
- Generalised mild tenderness
- No guarding, no rigidity
- No palpable mass
- Hepatomegaly — may be present if liver metastases
- Tympanic throughout
- No shifting dullness (no ascites)
- Reduced bowel sounds — ileus from electrolyte imbalance
- No succussion splash
- Left mastectomy scar visible on left chest wall
- Chest moves symmetrically
- Trachea central
- Reduced expansion on left (if pleural effusion)
- Dull on left base — pleural effusion (BRCA metastases)
- Reduced air entry at left base
- No added sounds on right
| Test | Finding | Relevance |
|---|---|---|
| GCS | 15/15 (alert) | — |
| Pupils | Equal, reactive to light | — |
| Fundoscopy | Possible papilloedema | Brain metastases → raised ICP |
| Peripheral sensation | Reduced in glove & stocking distribution | DM neuropathy + chemo neurotoxicity |
| Power | 5/5 all limbs (or reduced if mets) | — |
| Reflexes | Diminished distally | Peripheral neuropathy |
| Romberg's test | Positive | Neuropathy |
| Area | Finding | Relevance |
|---|---|---|
| Left axillary lymph nodes | May be enlarged | BRCA recurrence/spread |
| Supraclavicular lymph nodes | May be enlarged | Metastatic breast cancer |
| Spinal tenderness | Positive if bone mets | BRCA bone metastases |
| Rib tenderness | Positive if bone mets | BRCA bone metastases |
| Finding | Interpretation |
|---|---|
| Tachycardia | Dehydration, anaemia |
| Weak peripheral pulse | Dehydration |
| No murmur | Unless chemo-induced cardiomyopathy |
| No peripheral oedema | Or present if hypoalbuminaemia |
- Dehydration signs — dry mucosa, reduced skin turgor, tachycardia, low BP
- Left mastectomy scar + hysterectomy scar — confirms surgical history
- Alopecia — confirms chemotherapy
- Neurological signs — rule out brain metastases (headache + vomiting)
- Epigastric tenderness — GI involvement
There was a palpable 2x 2mass on her right upper outer quadrant of her breast..so these examination comes into what category
This is documented under Specific/Local Examination because it is directly relevant to her known diagnosis of breast cancer.
- Right breast — no visible skin changes
- No peau d'orange (skin dimpling)
- No nipple retraction/discharge
- Left breast absent — consistent with left mastectomy scar
- Palpable mass at right upper outer quadrant (UOQ)
- Size: 2 cm × 2 cm
- Shape: Round/irregular (to be described)
- Surface: Smooth or irregular (to be described)
- Consistency: Hard/firm (suspicious for malignancy)
- Margins: Well/poorly defined (to be described)
- Mobility: Fixed or mobile (fixed = sinister)
- Tenderness: Tender or non-tender
- Skin involvement: Present or absent
- Nipple involvement: Present or absent
- Right axillary lymph nodes — palpable/enlarged (suspicious for metastatic spread)
- Right supraclavicular lymph nodes — palpable/enlarged
- Right infraclavicular lymph nodes — check
| Feature | Interpretation |
|---|---|
| Right UOQ mass | Most common site for breast cancer (60% of breast cancers occur here) |
| Contralateral breast mass | High suspicion for new primary breast cancer or metastatic disease in the right breast |
| Known left BRCA history | Increases risk of contralateral breast cancer significantly |
| Currently on chemo | Mass persisting despite chemo — aggressive disease? |
EXAMINATION
│
├── General Examination
│ ├── Vital signs
│ ├── General inspection (pallor, cachexia, alopecia)
│ └── Hydration status
│
└── Specific/Local Examination
├── Abdominal Examination
├── Respiratory Examination
├── Breast Examination ← RIGHT HERE
│ └── 2×2 cm mass, right UOQ
├── Neurological Examination
└── Lymph Node Examination
On specific breast examination, the left breast was absent with a well-healed mastectomy scar noted. On palpation of the right breast, a 2 × 2 cm mass was palpable at the upper outer quadrant, with firm consistency and [mobile/fixed] margins. No nipple discharge or skin changes were noted. Right axillary lymph nodes were palpable, raising concern for contralateral breast malignancy or metastatic spread.
Size 2x 2, round, smooth, firm, well defined, mobile, non-tender, no skin or nipple involvement, right axillary lympg node palpable, Right supraclavicular lymph nodes palpable
- Left breast absent — well-healed left mastectomy scar noted
- Right breast — no skin changes, no peau d'orange, no erythema
- No nipple retraction or discharge
- No visible mass or asymmetry
| Feature | Finding |
|---|---|
| Location | Right upper outer quadrant (UOQ) |
| Size | 2 cm × 2 cm |
| Shape | Round |
| Surface | Smooth |
| Consistency | Firm |
| Margins | Well-defined |
| Mobility | Mobile |
| Tenderness | Non-tender |
| Skin involvement | Absent |
| Nipple involvement | Absent |
| Location | Finding | Significance |
|---|---|---|
| Right axillary lymph node | Palpable | Possible regional metastatic spread |
| Right supraclavicular lymph node | Palpable | Suggests advanced/metastatic disease — N3 staging |
| Left axillary | Not assessed (mastectomy side) | — |
On inspection, the left breast was absent with a well-healed mastectomy scar. The right breast showed no skin changes, peau d'orange, nipple retraction or discharge. On palpation, a 2 × 2 cm, round, smooth, firm, well-defined and mobile mass was noted at the right upper outer quadrant. The mass was non-tender with no skin or nipple involvement. Right axillary and right supraclavicular lymph nodes were palpable, raising concern for regional lymph node involvement.
| Feature | Interpretation |
|---|---|
| Round, smooth, well-defined, mobile | Could suggest benign (fibroadenoma) |
| Firm consistency | Raises suspicion for malignancy |
| Non-tender | Malignant masses are typically non-tender |
| Palpable right axillary LN | Suggests N1 nodal involvement |
| Palpable right supraclavicular LN | Suggests N3 disease — advanced staging |
| Known contralateral BRCA | High risk for new right breast primary |
| Component | Assessment |
|---|---|
| T | T1 (≤2 cm) or T2 (>2 cm) — borderline |
| N | N3 — supraclavicular node involvement |
| M | To be determined by imaging |
Palpable supraclavicular lymph node = N3 = Stage IIIC minimum — this is a red flag requiring urgent investigation.
Give me summary, provisional diag, ddx, results of ivx, definitive diag, outline of treatment
A middle-aged woman with a known history of Diabetes Mellitus (4 years) and left breast cancer (BRCA, 2020) — for which she underwent left mastectomy (2020) and is currently on chemotherapy (once every 6 months) and cancer medications — presented with a 10-day history of vomiting, 5 episodes/day. Vomitus was clear, containing undigested food. Associated symptoms include headache and abdominal pain, severity 7/10, exacerbated by oral intake. She also has a past surgical history of hysterectomy (2013) for uterine fibroids.
On examination, she appeared ill, cachexic, pale and dehydrated, with alopecia. Vital signs revealed tachycardia and hypotension consistent with dehydration. Breast examination revealed a 2×2 cm, round, smooth, firm, well-defined, mobile, non-tender mass at the right upper outer quadrant (UOQ) with no skin or nipple involvement. Right axillary and right supraclavicular lymph nodes were palpable.
1. Chemotherapy-Induced Nausea and Vomiting (CINV) — Most likely cause of vomiting given active chemotherapy use
2. Right breast malignancy — suspected contralateral breast cancer (new primary or metastatic) — 2×2 cm firm right UOQ mass + palpable right axillary and supraclavicular lymph nodes = highly suspicious
| Diagnosis | Reasoning |
|---|---|
| CINV (Chemotherapy-Induced N&V) | Most likely — on active chemo |
| Diabetic gastroparesis | DM for 4 years — delayed gastric emptying |
| Brain metastases | BRCA + headache + vomiting → raised ICP |
| Hypercalcaemia of malignancy | Bone mets → hypercalcaemia → N&V |
| Bowel obstruction | Cancer-related, vomits everything eaten |
| Medication side effects | Hormonal/targeted therapy causing GI upset |
| Diagnosis | Reasoning |
|---|---|
| Contralateral breast cancer (new primary) | Known BRCA history, firm mass, lymphadenopathy |
| Breast metastasis from left BRCA | Contralateral spread |
| Fibroadenoma | Round, smooth, mobile, well-defined — but firm and lymph nodes palpable |
| Breast cyst | Smooth and mobile — but firm consistency argues against |
| Investigation | Expected Result | Reason |
|---|---|---|
| FBC | Low Hb (anaemia), low WBC (neutropenia) | Chemotherapy bone marrow suppression |
| U&E / Electrolytes | Low K⁺, low Na⁺, low Cl⁻ | Prolonged vomiting |
| Blood glucose (RBS) | Low or unstable | Poor oral intake + DM medications |
| HbA1c | Elevated | Poorly controlled DM |
| Serum calcium | Elevated | Hypercalcaemia of malignancy (bone mets) |
| LFT | Elevated ALP, ALT | Liver metastases |
| Tumour markers — CA 15-3, CEA | Elevated | Breast cancer recurrence/metastasis |
| Serum albumin | Low | Malnutrition, malignancy |
| Coagulation profile | Deranged | Liver involvement, malignancy |
| Investigation | Expected Result | Reason |
|---|---|---|
| Right breast mammogram + ultrasound | Irregular/suspicious mass at UOQ | Characterise right breast mass |
| Core needle biopsy (right breast mass) | Malignant cells — confirm breast cancer | Gold standard for diagnosis |
| CT Chest/Abdomen/Pelvis | Lung mets, liver mets, lymphadenopathy | Full staging workup |
| CT/MRI Brain | Brain metastases | Headache + vomiting — raised ICP |
| Bone scan / PET scan | Bone metastases | Bone pain, elevated calcium |
| Abdominal ultrasound | Hepatomegaly, liver lesions | Liver metastases |
| Investigation | Expected Result |
|---|---|
| Core needle biopsy — right breast | Invasive ductal carcinoma (IDC) most likely |
| ER/PR/HER2 receptor status | Guides targeted therapy choice |
| Ki-67 index | High = aggressive tumour |
1. Contralateral (Right) Breast Cancer — new primary invasive breast carcinoma, right upper outer quadrant, with right axillary (N1) and supraclavicular (N3) lymph node involvement → Minimum Stage IIIC
2. Chemotherapy-Induced Nausea and Vomiting (CINV) — secondary to ongoing chemotherapy for left breast cancer
3. Dehydration — secondary to prolonged vomiting (10 days)
4. Diabetes Mellitus — pre-existing, likely poorly controlled given reduced oral intake
| Treatment | Rationale |
|---|---|
| IV fluid resuscitation — Normal saline or Hartmann's | Correct dehydration and electrolyte imbalance |
| Electrolyte replacement — IV KCl, NaCl | Correct hypokalaemia, hyponatraemia |
| Anti-emetics — Ondansetron (5-HT3 antagonist), Metoclopramide | Control CINV |
| Dexamethasone | Adjunct anti-emetic for CINV; also reduces cerebral oedema if brain mets |
| Blood glucose monitoring | Prevent hypoglycaemia — not eating, on DM meds |
| Adjust DM medications | Hold/reduce OHA or insulin while NBM/poor intake |
| Nutritional support — NGT feeding or TPN if unable to tolerate orally | Correct malnutrition |
| Treatment | Rationale |
|---|---|
| Multidisciplinary team (MDT) review | Oncology, surgery, radiology, pathology |
| Core needle biopsy — right breast mass | Confirm diagnosis, receptor status |
| Full staging workup — CT CAP, bone scan, MRI brain | Determine extent of metastatic disease |
| Systemic chemotherapy reassessment | Adjust regimen based on new diagnosis and receptor status |
| Hormonal therapy — Tamoxifen or Aromatase inhibitor (if ER/PR positive) | Reduces recurrence by 50%, prevents contralateral cancer — Goldman-Cecil Medicine |
| Targeted therapy — Trastuzumab (Herceptin) if HER2 positive | Targeted against HER2 receptor |
| Right mastectomy or lumpectomy | Depending on staging and patient preference |
| Radiotherapy | Post-surgical adjuvant therapy |
| Bone-protecting agents — Zoledronic acid, Denosumab | If bone metastases confirmed |
| Palliative care referral | If Stage IV/metastatic disease confirmed |
| Parameter | Frequency |
|---|---|
| Vital signs, fluid balance | Hourly (acute phase) |
| Blood glucose | 4-hourly |
| Electrolytes | Daily |
| Response to anti-emetics | Daily |
| Tumour markers (CA 15-3, CEA) | Each oncology visit |
Key take-home: This patient has two concurrent major issues — acute CINV with dehydration requiring immediate supportive care, and a highly suspicious right breast mass with lymph node involvement requiring urgent oncological workup. The palpable supraclavicular lymph node is a particularly sinister sign indicating at minimum Stage IIIC disease.